Argent BioPharma Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June
Jazz Pharmaceuticals The pharmaceutical giant announced last week that its flagship cannabinoid treatment, Epidyolex, failed to pass its Phase
Organigram has reported a 25% year-on-year increase in revenues over its third quarter as sales in its home market rebounded.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to
Canadian cannabis giant Organigram has announced a new three-year supply deal in the UK as it continues to focus efforts
As earnings season gets into full swing, Canada’s Organigram has become the latest major cannabis operator to publish its financial
Hopes of tax relief for Canada’s cannabis industry were derailed yesterday as the country’s Federal Budget 2024 revealed excise taxes
Canada’s House of Commons Standing Committee on Finance has recommended a change in how cannabis is taxed. This major change
Canadian cannabis producer Organigram has announced a further major investment from tobacco giant British American Tobacco (BAT). On November 06,
Canadian cannabis producer Organigram is set to bring its products to the UK’s medical cannabis market for the first time
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
